Click for best price
Metastatic Prostate Cancer Treatment Market Size, Share 2023
Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.
This report aims to provide a comprehensive presentation of the global market for Metastatic Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Prostate Cancer Treatment. This report contains market size and forecasts of Metastatic Prostate Cancer Treatment in global, including the following market information:
Global Metastatic Prostate Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Metastatic Prostate Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Mono Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Metastatic Prostate Cancer Treatment include AB Science, BeiGene, eFFECTOR Therapeutics, Immunomedics(Gilead Sciences, Inc.), Myovant Biosciences, SeleXel, Zenith Epigenetics Ltd., VasGene Therapeutics, Inc. and Telix Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Metastatic Prostate Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Prostate Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Metastatic Prostate Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
Mono
Combination
Mono/Combination
Global Metastatic Prostate Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Metastatic Prostate Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Drug Store
Online Pharmacy
Global Metastatic Prostate Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Metastatic Prostate Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Prostate Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metastatic Prostate Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metastatic Prostate Cancer Treatment, market overview.
Chapter 2: Global Metastatic Prostate Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Metastatic Prostate Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metastatic Prostate Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Metastatic Prostate Cancer Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Metastatic Prostate Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Prostate Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Prostate Cancer Treatment Overall Market Size
2.1 Global Metastatic Prostate Cancer Treatment Market Size: 2022 VS 2029
2.2 Global Metastatic Prostate Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Prostate Cancer Treatment Players in Global Market
3.2 Top Global Metastatic Prostate Cancer Treatment Companies Ranked by Revenue
3.3 Global Metastatic Prostate Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Prostate Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Metastatic Prostate Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Prostate Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Metastatic Prostate Cancer Treatment Market Size Markets, 2022 & 2029
4.1.2 Mono
4.1.3 Combination
4.1.4 Mono/Combination
4.2 By Type - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Metastatic Prostate Cancer Treatment Revenue, 2018-2023
4.2.2 By Type - Global Metastatic Prostate Cancer Treatment Revenue, 2024-2029
4.2.3 By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Prostate Cancer Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drug Store
5.1.4 Online Pharmacy
5.2 By Application - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Metastatic Prostate Cancer Treatment Revenue, 2018-2023
5.2.2 By Application - Global Metastatic Prostate Cancer Treatment Revenue, 2024-2029
5.2.3 By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Metastatic Prostate Cancer Treatment Market Size, 2022 & 2029
6.2 By Region - Global Metastatic Prostate Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Metastatic Prostate Cancer Treatment Revenue, 2018-2023
6.2.2 By Region - Global Metastatic Prostate Cancer Treatment Revenue, 2024-2029
6.2.3 By Region - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Metastatic Prostate Cancer Treatment Revenue, 2018-2029
6.3.2 US Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.3.3 Canada Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.3.4 Mexico Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Metastatic Prostate Cancer Treatment Revenue, 2018-2029
6.4.2 Germany Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.3 France Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.4 U.K. Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.5 Italy Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.6 Russia Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.4.8 Benelux Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Metastatic Prostate Cancer Treatment Revenue, 2018-2029
6.5.2 China Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.5.3 Japan Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.5.4 South Korea Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.5.6 India Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Metastatic Prostate Cancer Treatment Revenue, 2018-2029
6.6.2 Brazil Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.6.3 Argentina Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, 2018-2029
6.7.2 Turkey Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.7.3 Israel Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Metastatic Prostate Cancer Treatment Market Size, 2018-2029
6.7.5 UAE Metastatic Prostate Cancer Treatment Market Size, 2018-2029
7 Metastatic Prostate Cancer Treatment Companies Profiles
7.1 AB Science
7.1.1 AB Science Company Summary
7.1.2 AB Science Business Overview
7.1.3 AB Science Metastatic Prostate Cancer Treatment Major Product Offerings
7.1.4 AB Science Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.1.5 AB Science Key News & Latest Developments
7.2 BeiGene
7.2.1 BeiGene Company Summary
7.2.2 BeiGene Business Overview
7.2.3 BeiGene Metastatic Prostate Cancer Treatment Major Product Offerings
7.2.4 BeiGene Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.2.5 BeiGene Key News & Latest Developments
7.3 eFFECTOR Therapeutics
7.3.1 eFFECTOR Therapeutics Company Summary
7.3.2 eFFECTOR Therapeutics Business Overview
7.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Major Product Offerings
7.3.4 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.3.5 eFFECTOR Therapeutics Key News & Latest Developments
7.4 Immunomedics(Gilead Sciences, Inc.)
7.4.1 Immunomedics(Gilead Sciences, Inc.) Company Summary
7.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
7.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Major Product Offerings
7.4.4 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.4.5 Immunomedics(Gilead Sciences, Inc.) Key News & Latest Developments
7.5 Myovant Biosciences
7.5.1 Myovant Biosciences Company Summary
7.5.2 Myovant Biosciences Business Overview
7.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Major Product Offerings
7.5.4 Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.5.5 Myovant Biosciences Key News & Latest Developments
7.6 SeleXel
7.6.1 SeleXel Company Summary
7.6.2 SeleXel Business Overview
7.6.3 SeleXel Metastatic Prostate Cancer Treatment Major Product Offerings
7.6.4 SeleXel Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.6.5 SeleXel Key News & Latest Developments
7.7 Zenith Epigenetics Ltd.
7.7.1 Zenith Epigenetics Ltd. Company Summary
7.7.2 Zenith Epigenetics Ltd. Business Overview
7.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Major Product Offerings
7.7.4 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.7.5 Zenith Epigenetics Ltd. Key News & Latest Developments
7.8 VasGene Therapeutics, Inc.
7.8.1 VasGene Therapeutics, Inc. Company Summary
7.8.2 VasGene Therapeutics, Inc. Business Overview
7.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Major Product Offerings
7.8.4 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.8.5 VasGene Therapeutics, Inc. Key News & Latest Developments
7.9 Telix Pharmaceuticals
7.9.1 Telix Pharmaceuticals Company Summary
7.9.2 Telix Pharmaceuticals Business Overview
7.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Major Product Offerings
7.9.4 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.9.5 Telix Pharmaceuticals Key News & Latest Developments
7.10 Arvinas Inc.
7.10.1 Arvinas Inc. Company Summary
7.10.2 Arvinas Inc. Business Overview
7.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Major Product Offerings
7.10.4 Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.10.5 Arvinas Inc. Key News & Latest Developments
7.11 Amgen
7.11.1 Amgen Company Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Metastatic Prostate Cancer Treatment Major Product Offerings
7.11.4 Amgen Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.11.5 Amgen Key News & Latest Developments
7.12 Genentech
7.12.1 Genentech Company Summary
7.12.2 Genentech Business Overview
7.12.3 Genentech Metastatic Prostate Cancer Treatment Major Product Offerings
7.12.4 Genentech Metastatic Prostate Cancer Treatment Revenue in Global Market (2018-2023)
7.12.5 Genentech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Metastatic Prostate Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Metastatic Prostate Cancer Treatment Market Drivers in Global Market
Table 3. Metastatic Prostate Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Metastatic Prostate Cancer Treatment in Global Market
Table 5. Top Metastatic Prostate Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Metastatic Prostate Cancer Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Metastatic Prostate Cancer Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Metastatic Prostate Cancer Treatment Product Type
Table 9. List of Global Tier 1 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 30. AB Science Company Summary
Table 31. AB Science Metastatic Prostate Cancer Treatment Product Offerings
Table 32. AB Science Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. AB Science Key News & Latest Developments
Table 34. BeiGene Company Summary
Table 35. BeiGene Metastatic Prostate Cancer Treatment Product Offerings
Table 36. BeiGene Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. BeiGene Key News & Latest Developments
Table 38. eFFECTOR Therapeutics Company Summary
Table 39. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Offerings
Table 40. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. eFFECTOR Therapeutics Key News & Latest Developments
Table 42. Immunomedics(Gilead Sciences, Inc.) Company Summary
Table 43. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product Offerings
Table 44. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Immunomedics(Gilead Sciences, Inc.) Key News & Latest Developments
Table 46. Myovant Biosciences Company Summary
Table 47. Myovant Biosciences Metastatic Prostate Cancer Treatment Product Offerings
Table 48. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Myovant Biosciences Key News & Latest Developments
Table 50. SeleXel Company Summary
Table 51. SeleXel Metastatic Prostate Cancer Treatment Product Offerings
Table 52. SeleXel Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. SeleXel Key News & Latest Developments
Table 54. Zenith Epigenetics Ltd. Company Summary
Table 55. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product Offerings
Table 56. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Zenith Epigenetics Ltd. Key News & Latest Developments
Table 58. VasGene Therapeutics, Inc. Company Summary
Table 59. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 60. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. VasGene Therapeutics, Inc. Key News & Latest Developments
Table 62. Telix Pharmaceuticals Company Summary
Table 63. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Offerings
Table 64. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Telix Pharmaceuticals Key News & Latest Developments
Table 66. Arvinas Inc. Company Summary
Table 67. Arvinas Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 68. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Arvinas Inc. Key News & Latest Developments
Table 70. Amgen Company Summary
Table 71. Amgen Metastatic Prostate Cancer Treatment Product Offerings
Table 72. Amgen Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Amgen Key News & Latest Developments
Table 74. Genentech Company Summary
Table 75. Genentech Metastatic Prostate Cancer Treatment Product Offerings
Table 76. Genentech Metastatic Prostate Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Genentech Key News & Latest Developments
List of Figures
Figure 1. Metastatic Prostate Cancer Treatment Segment by Type in 2022
Figure 2. Metastatic Prostate Cancer Treatment Segment by Application in 2022
Figure 3. Global Metastatic Prostate Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metastatic Prostate Cancer Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Metastatic Prostate Cancer Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 16. US Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 28. China Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. AB Science Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BeiGene Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SeleXel Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Amgen Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Genentech Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
